Phio Pharmaceuticals Corp
Company Overview
Phio Pharmaceuticals Corp is a biotechnology company developing novel therapeutic treatments using its proprietary self-delivering RNAi (INTASYL™) therapeutic platform. The company focuses on immuno-oncology, targeting tumor cells and various cells of the immune system to improve the efficacy of immunotherapy treatments.
The company is currently in the development phase and does not generate revenue from its products, as they are still in various clinical trial stages. Their primary focus is on advancing their pipeline of therapeutic candidates through research and development.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Phio Pharmaceuticals Corp's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.